Home Gains Buoy Cipla In Q1 But US Momentum Pivotal

Steps
ROBUST GROWTH AT HOME LIFTS CIPLA BUT ALL EYES ON US MOMENTUM
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia